The Covid-19 pandemic is poised to be a defining moment for the U.S. health care industry. Even as organizations across the country continue to grapple with the immediate impact of the outbreak, leaders are also beginning to plan for the future—with the understanding that the pandemic is reshaping and restructuring the industry in ways that are likely to be permanent. While all can agree that the post-Covid landscape is likely to look notably different from the pre-Covid reality, there is considerable debate about the degree and nature of change the industry will experience.

Read on to get Advisory Board’s take on how Covid-19 will reshape demand, purchaser strategies, the competitive landscape, and delivery models.